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Levo-tetrahydropalmatine (l-THP) is an alkaloid found in many 
traditional Chinese herbal preparations and has a unique pharmacological 
profile that includes dopamine receptor antagonism. Previously we 
demonstrated that l-THP attenuates fixed-ratio (FR) cocaine self-
administration (SA) and cocaine-induced reinstatement in rats at doses that 
do not alter food-reinforced responding. This study examined the effects of l-
THP on cocaine and food SA under progressive-ratio (PR) schedules of 
reinforcement and the discriminative stimulus effects of cocaine. In adult 
male Sprague-Dawley rats self-administering cocaine (0.5 or 1.0 mg/kg/inf), 
l-THP significantly reduced breaking points at the 1.875, 3.75 and 7.5 mg/kg 
doses. l-THP also reduced the breaking points and response rates for PR SA of 
sucrose-sweetened food pellets, although the decrease was significant only at 
the 7.5 mg/kg l-THP dose. In rats trained to discriminate cocaine (10 mg/kg, 
ip) from saline, l-THP (1.875, 3.75 and 7.5 mg/kg) produced a rightward shift 
in the dose-response curve for cocaine generalization. During generalization 
testing, l-THP reduced response rate, but only at the 7.5 mg/kg dose. l-THP 
also prevented substitution of the dopamine D2/D3 receptor agonist, (+/−) 7-
OH-DPAT, for cocaine suggesting a potential role for antagonism of D2 and/or 
D3 receptors in the effects of l-THP. These data further demonstrate that l-
THP attenuates the reinforcing and subjective effects of cocaine at doses that 
do not produce marked motor effects and provide additional evidence that l-
THP may have utility for the management of cocaine addiction. 
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1. Introduction 
Although a number of potentially promising medications have 
been identified for treating drug-dependent individuals (Vocci et al., 
2005), a demand still exists for new and more effective medicinal 
approaches. Despite their potential efficacy, traditional herbal 
preparations are often not considered to be viable options for treating 
drug addiction, due in part to the paucity of reliable clinical and 
preclinical studies examining their utility. However, there has been a 
recent effort by many to test the effectiveness of such agents and 
their active constituents using accepted preclinical disease models and 
well-controlled clinical trials (De Smet, 2002; Ernst, 2005). 
Tetrahydropalmatine (THP) is a tetrahydroprotoberberine 
(THPB) isoquinoline alkaloid and a primary active constituent of herbal 
preparations containing plant species of the genera Stephania 
(Menispermaceae family) and Corydalis (Fumariaceae family) including 
Bin Ju Huan, Yan Hu Suo, Di Bu Long and Hua Jian Jiu Teng. Two of 
these species, Corydalis ambigua (yan hu suo) and Stephania tetranda 
(fang ji) are among the 50 fundamental herbs in Chinese herbology 
and have been used traditionally for their sedative, neuroleptic and 
analgesic properties (Ding, 1987). In particular, the levo isomer of THP 
(l-THP) appears to contribute to many of the therapeutic effects of 
these preparations through its actions at DA receptors (Jin, 1987; Chu 
et al., 2008). 
A large body of data indicates that l-THP is an antagonist at 
dopamine (DA) D1 and D2 receptors (Jin et al., 1986; Jin, 1987; Xu et 
al., 1989; Wu et al., 1990; Zhu et al., 1991; Huang and Jin, 1992; 
Sun et al., 1992; Guo et al., 1997; Hu and Jin, 1999; Mantsch et al., 
2007). Considering the involvement of dopaminergic 
neurotransmission in cocaine abuse and addiction (Volkow et al., 
2004; Anderson and Pierce, 2005), compounds such as l-THP which 
antagonize DA receptors have long been thought to represent potential 
medications for the management of cocaine addiction. However, 
despite its promise, this approach has been largely unsuccessful for 
treating cocaine addiction due to lack of efficacy and/or the occurrence 
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of use limiting side effects such as sedation and anhedonia, 
attributable in part to undesirable pharmacological profiles (Platt et al., 
2002). Compared to many other DA receptor antagonist drugs, l-THP 
has lower affinity for D2 DA receptors relative to D1 receptors (Jin, 
1987). l-THP also binds to D3 DA receptors (Mantsch et al., 2007), 
likely functioning as an antagonist, and has secondary actions at a 
number of non-DA receptors (see e.g., Lu et al., 1996; Halbsguth et 
al., 2003). The unique pharmacological profile of l-THP distinguishes it 
from other DA antagonist drugs and may make it a more suitable 
medication for treating cocaine addiction. 
We (Mantsch et al., 2007) and others (Xi et al., 2007) have 
recently demonstrated that l-THP attenuates cocaine self-
administration (SA; Mantsch et al., 2007; Xi et al., 2007), cocaine-
evoked reinstatement (Mantsch et al., 2007) and cocaine-induced 
reductions in intracranial self-stimulation (ICSS) thresholds (Xi et al., 
2007) in rats at doses that produce little or no impairment of motor 
function. Along with the findings of a recent preliminary clinical trial 
demonstrating that l-THP attenuates craving and relapse in recovering 
heroin addicts (Yang et al., 2008), these data suggest that further 
investigation of the utility of l-THP for the treatment of cocaine 
addiction is warranted. 
In the present study we investigated the ability of l-THP isolated 
from the roots of Stephania delavayi Diels (Di Bu Long) acquired from 
Yunnan province in China to attenuate cocaine’s reinforcing and 
subjective properties by testing for l-THP effects on cocaine SA under a 
progressive ratio (PR) schedule and cocaine generalization in rats 
trained to discriminate cocaine from saline. In an attempt to further 
dissociate l-THP interference with cocaine’s subjective/reinforcing 
effects from its sedative/motor effects, we also examined the effects of 
l-THP on food-reinforced responding either concurrently with 
generalization testing using the drug discrimination approach or in 
separate rats trained to self-administer sucrose-sweetened food pellets 
under an identical PR schedule of reinforcement. Finally, the potential 
role of DA D2/D3 receptor antagonism in the effects of l-THP was 
investigated by examining the effects of l-THP on the cocaine-like 
discriminative stimulus effects of the D2/D3 receptor agonist drug, 
(+/−) 7-OH-DPAT. 
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Fifty-six adult male Sprague-Dawley rats were used for the 
study. Thirteen total rats were used to test the effects of l-THP on the 
discriminative stimulus effects of cocaine. Twenty-four total rats were 
used to test the effects of l-THP on PR cocaine SA. Nineteen total rats 
were used to test the effects of l-THP on PR food SA. All rats were 
housed singly in a temperature- and humidity-controlled, AAALAC-
accredited animal facility under a reversed 12 h/12 h light/dark cycle 
(lights on at 7:00 PM). For the drug discrimination and food PR SA 
experiments, rats were food restricted and maintained at 90% of their 
free-feeding body weight determined at the start of the study. For the 
cocaine PR SA study, rats had free access to food, except when in the 
experimental chambers. All procedures were carried out in accordance 
with the Guide for the Care and Use of Laboratory Animals as adopted 
and promulgated by the NIH. 
2.2. Drugs 
Cocaine HCl was acquired from the National Institute on Drug 
Abuse (NIDA) through the NIDA Drug Supply Program. l-THP was 
isolated from the crushed and dried tuberous roots of Stephania 
delavayi Diels (Di Bu Long) grown in Yunnan province in China and 
was acquired from the Beijing Basic Science Research Institute 
(Beijing, China). The purity of the isolated l-THP was greater than 
99%, as determined using HPLC. Cocaine was dissolved in saline 
(0.9% NaCl solution). l-THP was dissolved in sterile water and 
administered at doses of 1.875, 3.75 and 7.5 mg/kg, ip. Some rats 
were also tested for drug discrimination in combination with a 15 
mg/kg l-THP dose (data not shown). However, due to high levels of 
sedation, these rats were unable to complete the response 
requirements for testing. For this reason we limited all subsequent 
testing to the lower l-THP doses. (+/−) 7-OH-DPAT (7-hydroxy-N,N-
din-propylaminotetralin) was purchased from Sigma-Aldrich and was 
dissolved in saline and was administered at doses of 0.1, 0.3, and 1.0 
mg/kg (ip). 
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Twenty plastic and stainless steel operant conditioning 
chambers encased in sound attenuating cubicles (MED-Associates Inc., 
St Albans, VT) were used. Chambers were equipped with retractable 
levers with stimulus lights located above them. Two levers and their 
corresponding stimulus lights were mounted on the front wall of the 
chamber. A food pellet dispenser receptacle was located between the 
two levers on the front wall. Cubicles were equipped with exhaust fans 
that provided ventilation and white noise to mask extraneous sound. 
The operant conditioning chambers were interfaced with computers 
containing Med-PC software for automated control of testing conditions 
and data collection. 
2.4. Progressive Ratio Self-Administration 
2.4.1. Catheterization Surgery  
For the PR cocaine SA experiment, rats were implanted with 
chronic indwelling catheters under ketamine HCl (100 mg/kg, ip, Fort 
Dodge Animal Health, Fort Dodge, IA) and xylazine (2 mg/kg, ip, Lloyd 
Laboratories, Shenandoah, IA) anesthesia as previously reported 
(Mantsch et al., 2007). A silicon tubing catheter (Silastic®; Dow 
Corning Co., Midland, MI; 0.64 mm i.d.; 1.19 mm o.d.) was inserted 
into the right posterior facial vein and down into the jugular vein so 
that it terminated at right atrium. The catheter was sutured to the vein 
and continued subcutaneously to the animal’s back where it exited 2 
cm posterior to the scapula via a back-mounted 22-gauge guide 
cannula (Plastics One Inc., Roanoke, VA) attached using dental acrylic 
to a piece of polypropylene monofilament surgical mesh (Atrium 
Medical, Co., Hudson, NH) to permit connection of a polyethylene 
delivery line (0.58 mm i.d. × 1.27 mm o.d.; Plastics One Inc., 
Roanoke, VA) encased in a stainless steel spring leash (Plastics One). 
The delivery line was connected to a 30-ml syringe in a motor-driven 
pump (Razel, Stamford, CT) via a leak-proof fluid swivel (Instech Lab. 
Inc., Plymouth Meeting, PA) suspended above the chamber to allow 
drug solution delivery. The swivel and leash assembly was counter-
balanced to permit relatively unrestrained movement. Rats were 
allowed to recover for at least three days prior to SA testing during 
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time they were provided acetaminophen (480 mg/L) in their drinking 
water. After implantation, rats were injected with a sterile cefazolin 
antibiotic solution (15 mg, iv; West-Ward Pharmaceutical Co., 
Eatontown, NJ) each day that they were tested, until the end of the 
study. Catheters were filled daily with a heparin solution (83 i.u./ml; 
Elkins-Sinn, Inc., Cherry Hill, NJ) and capped whenever the 
leash/delivery line assembly was disconnected. 
2.4.2. Effects of l-THP on Progressive Ratio Cocaine Self-
Administration  
Rats were initially trained to press a lever under a FR1 schedule 
of food pellet reinforcement prior to catheter implantation. Following 
recovery from surgery, rats were trained to self-administer cocaine 
(1.0 or 0.5 mg/kg/inf delivered over 5 sec) by pressing the active 
lever under a FR1 schedule. Drug availability was signaled by 
illumination of the house light in the chamber. During the drug 
infusion, the houselight was turned off and the stimulus light above 
the lever was illuminated. Each infusion was followed by a 10-sec 
time-out period during which the stimulus and house lights were off. 
Once stable SA was observed (responding within 10% of the mean 
over 3 consecutive sessions), rats were switched to a PR schedule. 
Under this schedule the response requirement for cocaine delivery was 
increased with successive infusions using the following progression: 
1,2,4,6,9,12,15,20,25,32,40,50,62,77,95,118,145,178,219,268,328, 
402,492,603,737,901,1102,1347,1646,2012 (Richardson and Roberts, 
1996). The progression continued until the tested rat failed to 
complete the ratio requirements within a 1-h period. The breaking 
point was defined as the number of infusions self-administered prior to 
failure to meet the ratio requirements. Once stable PR SA was 
observed (breaking points within 10% of the mean over 3 consecutive 
sessions), the effects of l-THP were tested by pre-treating rats with l-
THP (1.875, 3.75 or 7.5 mg/kg, ip) or vehicle 30 minutes prior to PR 
SA testing. Initially 18 rats were tested for the effects of vehicle and 
all three l-THP doses on PR SA of 1.0 mg/kg/inf cocaine. Subsequently, 
in order to determine the relationship between the dose of cocaine 
available for SA and the effects of l-THP, another group of six rats was 
tested for the effects of vehicle and 1.875 and 3.75 mg/kg l-THP on PR 
SA of 0.5 mg/kg/inf cocaine. 
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2.4.3. Effects of l-THP on Progressive Ratio Food Self-
Administration  
In order to examine the effects of l-THP on PR SA of a non-drug 
reinforcer, separate groups of rats were trained to self-administer 
sucrose-sweetened food pellets (45 mg; BioServ) under a PR schedule 
identical to that used for cocaine SA. Once stable PR SA was observed 
in these rats, they were tested for the effects of l-THP as described 
above. Thirteen rats were tested for the effects of vehicle and 3.75 
and 7.5 mg/kg l-THP on PR food SA. A separate group of seven rats 
was tested for the effects of vehicle and 1.875 mg/kg l-THP on PR food 
SA. 
2.5. Drug Discrimination 
A total of 13 rats were trained to discriminate cocaine (10 
mg/kg, ip) from saline (0.9% NaCl) using a 2-lever FR20 sucrose-
sweetened food pellet (45 mg; BioServ, Frenchtown, NJ) reinforced 
drug discrimination design similar to that previously described 
(Mantsch and Goeders, 1999). These rats were food restricted and 
maintained at 90% of their initial free-feeding body weights. For each 
rat, one lever on the front wall on the chamber was designated as the 
cocaine-appropriate lever and the other as the saline-appropriate 
lever. Initially, rats were trained to press each of the levers under a 
FR1 schedule during separate sessions on alternating days. Once rats 
consistently acquired at least 100 food pellets during both —left and —
right lever sessions, errorless training began. During errorless training, 
rats were injected with 10 mg/kg cocaine or saline (ip) 15 min prior to 
the training session during which only the designated treatment-
appropriate lever was available (i.e., extended) and active and the 
corresponding stimulus light illuminated. Errorless training sessions 
last for 30 min or until 100 reinforcers were delivered. Training began 
under an FR1 schedule of reinforcement and this ratio was gradually 
increased to FR20. Once 100 food pellets were acquired under the 
FR20 schedule of reinforcement within 30 minutes after both cocaine 
and saline treatments, discrimination training began. During 
discrimination training, both levers were extended into the chamber 
and their corresponding stimulus lights were illuminated, but only 
responding on the treatment-appropriate lever was reinforced under 
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the FR20 schedule. There were no programmed consequences of 
responding on the treatment inappropriate lever. Discrimination 
training continued until at least 85% of all responses prior to the 
delivery of the first reinforcer was on the treatment-appropriate lever 
for at least 9 out of 10 consecutive sessions. Throughout training, 
which was conducted five to six days weekly, the sequence of saline 
and cocaine exposure was randomized. However, neither cocaine nor 
saline treatment was administered for more than two consecutive 
training sessions. 
2.5.1. Effects of l-THP on Cocaine Discrimination  
Of the 13 rats that were trained, seven were tested for the 
effects of 3.75 and 7.5 mg/kg l-THP and vehicle on cocaine 
discrimination. The remaining six were tested initially for the effects of 
1.875 mg/kg l-THP on cocaine discrimination and then were tested 
later for the effects of l-THP on (±) 7-OH-DPAT substitution (see 
section 2.5.2). Generalization testing was conducted twice weekly, 
usually on Tues and Fri. During generalization test sessions, both 
levers were extended and both stimulus lights illuminated. These 
sessions were terminated immediately following 20 responses on 
either lever (combined) with no food pellet delivery, or after 30 min 
elapsed. Generalization was defined as the percent of total responses 
(i.e., 20) emitted on the cocaine-appropriate lever. The effects of l-
THP on cocaine generalization were tested by examining cocaine-
appropriate responding during test sessions preceded by 
administration of various cocaine doses (0, 1.25, 2.5, 5.0, and 10.0 
mg/kg, ip) after treatment with l-THP (1.875, 3.75 or 7.5 mg/kg, ip) 
or vehicle 30 min prior to cocaine delivery. Generalization test sessions 
were separated by additional training sessions during which rats were 
required to display 85% treatment-appropriate responding for at least 
two consecutive sessions (one cocaine and one saline). The sequences 
of cocaine and l-THP dose testing were counterbalanced according to a 
Latin square design to avoid potential sequence effects. During 
generalization testing, response rate (resp/min) was also recorded to 
permit concurrent examination of motor effects. 
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2.5.2. Effects of l-THP on (±) 7-OH-DPAT Substitution for 
Cocaine  
To examine the potential role of DA D2 and D3 receptor 
antagonism in the effects of l-THP on cocaine discrimination, six rats 
were tested for the effects of l-THP on the substitution of the DA 
D2/D3 receptor agonist, (±)7-OH-DPAT for cocaine in rats trained to 
discriminate 10 mg/kg cocaine from saline. These six rats were also 
used earlier to test for the effects of 1.875 mg/kg l-THP on cocaine 
discrimination. (±) 7-OH-DPAT (0.1, 0.3 or 1 mg/kg, ip) or vehicle was 
administered 30 minutes prior to generalization testing and 30 minutes 
after pretreatment with l-THP (1.875 or 3.75 mg/kg, ip) or vehicle. 
Testing was conducted as described above (section 2.5.1.). 
2.6. Statistical Analyses 
The effects of l-THP on breaking points for PR SA were 
examined using one-way repeated measures ANOVA when examining 
effects only at the 1.0 mg/kg/inf cocaine dose or two-way cocaine 
dose (between subjects measure) × l-THP dose (repeated measure) 
ANOVA when comparing effects of l-THP at the 0.5 and 1.0 mg/kg/inf 
doses. The effects of l-THP on breaking points and response rates 
during PR food SA were examined using two-way l-THP treatment (l-
THP vs. vehicle; repeated measure) × l-THP dose (between subjects 
measure) ANOVA. The effects of l-THP on the dose-response curve for 
cocaine generalization and response rate and on (±) 7-OH-DPAT 
substitution for cocaine during generalization testing were examined 
using 2-way ANOVA with cocaine dose as a repeated measure and l-
THP dose as a between subjects measure for cocaine substitution and 
as a within subjects measure for (±) 7-OH-DPAT substitution. Effective 
dose 50% (ED50) values for cocaine generalization alone or in 
combination with the two l-THP were calculated via non-linear 
regression using GraphPad Prism software based on the following 
equation used to generate a sigmoidal dose response curve: Y=Bottom 
+ (Top-Bottom)/(1+10^((LogEC50-X))) where X is the logarithm of 
cocaine dose and Y is the response, starting at Bottom and going to 
Top with a sigmoid shape. Effects of l-THP on ED50 values were 
examined using one-way ANOVA. Bonferroni-corrected t-tests were 
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used for all post-hoc testing. In all cases statistical significance was 
defined as P <0.05. 
3. Results 
3.1. Progressive Ratio Cocaine Self-Administration 
Eighteen total rats were tested for the effects of l-THP on SA of 
1.0 mg/kg/inf cocaine under a PR schedule (Figure 1A). One-way 
repeated measures ANOVA showed a significant effect of l-THP on the 
breaking point for PR SA (F3,51=8.136; P<0.001). l-THP dose-
dependently reduced the breaking point for SA. Post-hoc testing using 
Bonferroni-corrected t-tests showed significant reductions in breaking 
point (P<0.01) compared to vehicle pretreatment following 
administration of the 3.75 and 7.5 mg/kg, but not 1.875, mg/kg l-THP 
at this self-administered cocaine dose. 
 
Figure 1 l-THP attenuated cocaine self-administration under a progressive ratio 
schedule of reinforcement. Data in Figure 1A represent the mean breaking point (self-
administered infusions ± SE) during the SA session following pretreatment with l-THP 
(1.875, 3.75, or 7.5 mg/kg, ip) or vehicle (VEH) in rats self-administering 1.0 
mg/kg/inf cocaine (n=18; *P<0.05 vs. VEH). Data in Figure 2B show the effects of l-
THP (1.875 or 3.75) or vehicle (VEH) on breaking points in separate groups of rats 
self-administering 0.5 (n=6) or 1.0 (n=18) mg/kg/inf cocaine (#P<0.05; significant 
overall effects of 1.875 and 3.75 mg/kg l-THP vs. VEH). 
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To further examine the effects of l-THP on PR cocaine SA, a 
second group of rats (n=6) was tested for the effects of 1.875 and 
3.75 mg/kg l-THP and vehicle on SA of a lower cocaine dose (0.5 
mg/kg/inf) under a PR schedule (Figure 1B). For statistical analysis, 
the breaking point for this group of rats was compared to rats tested 
for the effects of the same l-THP doses on SA of 1.0 mg/kg/inf cocaine 
using a 2-way cocaine dose (between subjects measure) × l-THP dose 
(repeated measure) ANOVA. A significant overall effect of cocaine dose 
was observed (F1,22=6.112;P<0.05) with a higher breaking point 
observed at the higher cocaine dose, suggesting that these cocaine 
doses were located on the ascending limb of the SA dose-response 
curve. A significant overall effect of l-THP dose, but no interaction 
between l-THP dose and cocaine dose was also found 
(F1,22=22.553;P<0.001). l-THP dose-dependently reduced the breaking 
point for cocaine SA with significant overall reductions observed at 
both the 1.875 and 3.75 mg/kg doses (P<0.05; Bonferroni-corrected 
t-tests), consistent with a rightward and/or downward shift in the SA 
dose-response curve. 
3.2. Progressive Ratio Food Self-Administration 
To investigate the potential contribution of non-specific motor 
and anhedonic effects of l-THP to the observed reductions in breaking 
points for PR cocaine SA, separate groups of rats were tested for the 
effects of the 1.875, 3.75 and 7.5 mg/kg l-THP doses on the SA of 
sucrose-sweetened food pellets under an identical PR schedule of 
reinforcement. Notably, under basal conditions, the breaking points for 
food and 1.0 mg/kg/inf cocaine did not significantly differ (15.20 ± 
0.84 for 1.0 mg/kg/inf cocaine vs. 15.06 ± 0.56 for food SA). 
Thirteen rats were tested for the effects of 3.75 and 7.5 mg/kg 
l-THP on PR food SA. A separate group of six rats was tested for the 
effects of 1.875 mg/kg l-THP on PR food SA. The effects of l-THP on 
the breaking point for SA (i.e., the number of food pellets self-
administered under the PR schedule) are shown in Figure 2A. A 2-way 
l-THP treatment (l-THP vs. Veh; repeated measure) × l-THP dose 
condition (1.875, 3.75. and 7.5 mg/kg l-THP; between subjects 
measure) ANOVA showed a significant overall effect of l-THP treatment 
(F1,29=7.328; P<0.05), but not l-THP dose, on the breaking point for 
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PR food SA, and a significant l-THP treatment × dose interaction 
(F2,29=7.134; P<0.01). Post-hoc testing using Bonferroni-corrected t-
tests showed that a significant reduction in the breaking point for food 
SA compared to vehicle treatment was only observed at the 7.5 mg/kg 
l-THP dose (P<0.01). 
 
Figure 2 Effects of l-THP on breaking point and response rate in rats self-
administering sucrose-sweetened food pellets under a PR schedule. l-THP attenuated 
both breaking point and response rate, but only at the 7.5 mg/kg dose (*P<0.05 vs. 
VEH). Data represent mean breaking points (food pellets acquired ± SE; Fig 2A) or 
response rates (resp/min ± SE; Fig 2B) during the PR SA sessions following 
pretreatment with 1.875 (n=7), 3.75 (n=13), or 7.5 (n=13) mg/kg l-THP (ip) or 
vehicle (Veh). 
Since effects on breaking point can be independent of effects on 
response rate, we also examined the effects of l-THP on the rate of 
lever pressing (responses per minute) during the food PR SA sessions 
(Figure 2B). A 2-way l-THP treatment (l-THP vs. Veh; repeated 
measure) × l-THP dose condition (1.875, 3.75. and 7.5 mg/kg l-THP; 
between subjects measure) ANOVA showed significant main effects of 
l-THP treatment (F1,29=10.604; P<0.01) and l-THP dose (F2,29=6.289; 
P<0.01) on response rate and a significant l-THP treatment × dose 
interaction (F2,29=8.246; P=0.001 ). Post-hoc testing showed that, 
similar to the effect on breaking point, reductions in response rate by 
l-THP compared to vehicle treatment were only observed at the 7.5 
mg/kg l-THP dose (P<0.001). 
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3.3. Drug Discrimination 
Seven rats were used to examine the effects of vehicle and 3.75 
and 7.5 mg/kg l-THP on cocaine discrimination. A separate group of 
six rats was used to examine the effects of 1.875 mg/kg l-THP on 
cocaine discrimination. Two-way l-THP dose (between subjects 
measure) × cocaine dose (repeated measure) ANOVA was used to 
examine the effects of l-THP on the dose-response curve for cocaine 
substitution for the 10 mg/kg, ip training dose (Fig 3A). Significant 
overall effects of cocaine dose (F4,92=109.540; P<0.001) and l-THP 
dose (F3,23=16.659; P<0.001) and a significant cocaine dose × l-THP 
dose interaction (F12,92=10.092;P<0.001) were found. Overall, dose-
dependent substitution for the cocaine training dose was observed. 
Post-hoc analysis showed that, overall, the 3.75 and 7.5, but not the 
1.875, mg/kg doses of l-THP attenuated cocaine generalization 
(Bonferroni-corrected t-test; P<0.001). To further examine the effects 
of l-THP on cocaine-induced generalization, one-way ANOVA of l-THP 
effects followed by post-hoc testing was conducted at each individual 
cocaine dose. Effects of l-THP on cocaine-appropriate responding were 
observed at the 1.25 mg/kg (F3,26=3.076), 2.5 mg/kg (F3,26=16.272), 
and 5.0 mg/kg (F3,26=15.472) doses, but not the 0 or 10 mg/kg doses, 
with post-hoc analyses revealing significant reductions by all three l-
THP doses compared to vehicle at the 2.5 mg/kg cocaine dose and by 
the 3.75 and 7.5, but not 1.875, mg/kg l-THP doses at the 5.0 mg/kg 
cocaine dose (Bonferroni-corrected t-test; P<0.05). 
 
Figure 3 l-THP, at doses that did not alter response rate, dose-dependently 
attenuated cocaine-appropriate responding during generalization testing in rats trained 
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to discriminate cocaine (10 mg/kg, ip) from saline. Data in represent the mean 
percent responding on the cocaine-appropriate lever (±SE; Fig 3A) and rate 
(resp/min; Fig 3B) during generalization testing during following administration of 
cocaine (0–10 mg/kg, ip) in rats pretreated with 1.875 (n=6), 3.75 (n=7) or 7.5 
(n=7) mg/kg l-THP (ip) or vehicle (Veh; n=7). l-THP significantly attenuated cocaine-
appropriate responding at each dose tested (*P<0.05 for each l-THP dose vs. Veh 
control; #P<0.05, 3.75 and 7.5 mg/kg l-THP only vs. Veh) but only reduced response 
rate at the 7.5 mg/kg l-THP dose (+P<0.05, significant overall effect of l-THP dose; 
**P<0.05, 7.5 mg/kg l-THP only vs. Veh). 
Since both doses of l-THP did not completely suppress, but 
rather produced a rightward shift in, the dose response curve for 
generalization, we were also able to generate and compare ED50 values 
for cocaine-induced generalization in rats pretreated with l-THP or 
vehicle. ED50 values for cocaine generalization (mg/kg ± S.E.) were as 
follows: 2.16 ± 0.24 for vehicle pretreated rats; 4.04 ± 1.24 for rats 
pretreated with 1.875 mg/kg l-THP; 45.98 ± 0.69 for rats pretreated 
with 3.75 mg/kg l-THP; and 7.83 ± 1.24 for rats pretreated with 7.5 
mg/kg l-THP. One-way ANOVA showed a significant effect of l-THP 
treatment condition on ED50 values for cocaine generalization 
(F3,26=12.031; P<0.001). Post-hoc testing using Bonferroni-corrected 
t-tests showed that the cocaine generalization ED50 was significantly 
increased in rats pretreated with the 3.75 and 7.5 mg/kg l-THP doses, 
but not the 1.875 mg/kg l-THP dose compared to vehicle pretreated 
rats (P<0.01 for each comparison). 
Two-way l-THP dose (between subjects measure) × cocaine 
dose (repeated measure) ANOVA was also used to examine the effects 
of l-THP on the rate of responding (resp/min) during generalization 
testing across the various cocaine doses (Fig 3B). A significant overall 
effects of cocaine dose (F4,92=9.003; P<0.001), but not l-THP dose, 
and a significant cocaine dose × l-THP dose interaction 
(F12,92=2.094;P<0.05) were found. Overall, response rate 
progressively decreased as the cocaine dose tested for generalization 
increased. Isolation of l-THP effects using one-way ANOVA at each 
cocaine dose showed that l-THP significantly altered response rate only 
at the 2.5 mg/kg cocaine dose (P<0.05 for each analysis). Post-hoc 
comparison (Bonferroni-corrected t-test) showed that the 7.5 mg/kg, 
but not the 3.75 mg/kg or the 1.875, l-THP dose significantly reduced 
response rate (P<0.01) when rats were tested at the 2.5 mg/kg 
cocaine dose. Despite a trend towards an l-THP induced reduction 
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during vehicle testing (P=0.055), statistically significant effects were 
not observed. Thus, although l-THP had rate-suppressing effects at the 
highest (i.e., 7.5 mg/kg) dose tested, these effects were not found 
with the lower (i.e., 1.875 or 3.75 mg/kg) l-THP doses, at which 
attenuation of cocaine’s discriminative stimulus effects was observed. 
To determine if the ability of l-THP to block DA D2/D3 receptors 
may have contributed to its effects on cocaine discrimination, the 
effects of l-THP (1.875 or 3.75 mg/kg, ip) or vehicle on the 
substitution of the D2/D3 agonist, (±) 7-OH-DPAT (0, 0.1, 0.3 and 1.0 
mg/kg) for cocaine in rats (n=6) trained to discriminate 10 mg/kg 
cocaine from saline was examined (Figure 4). Two-way repeated 
measure (±) 7-OH-DPAT dose × l-THP dose ANOVA examining (±) 7-
OH-DPAT substitution for cocaine, defined as responding on the 
cocaine-appropriate lever, showed significant overall effects of (±) 7-
OH-DPAT (F3,15=52.820 ; P<001) and l-THP (F2,10=12.135;P<0.01) 
and a significant (±) 7-OH-DPAT dose × l-THP dose interaction 
(F6,30=4.770;P<0.01). l-THP dose-dependently substituted for cocaine 
with approximately 80 percent cocaine-appropriate responding at the 
two highest l-THP doses. Post-hoc analysis showed significant overall 
reductions in cocaine-appropriate responding after (±) 7-OH-DPAT 
administration following pretreatment with either l-THP dose tested 
(P<0.05 for each; Bonferroni-corrected t-tests). Effects of l-THP at 
each (±) 7-OH-DPAT dose were further examined using one-way 
repeated measures ANOVA. A significant l-THP effect was found at the 
0.3 mg/kg (±) 7-OH-DPAT dose (F2,10=23.280;P<0.001), but not the 
other doses, with significant reductions in cocaine-appropriate 
responding compared to vehicle observed at each l-THP dose tested 
(P<0.05 for each; Bonferroni- corrected t-tests). 
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Figure 4 l-THP dose-dependently attenuated substitution of (±) 7-OH-DPAT for 
cocaine in rats (n=6) trained to discriminate cocaine (10 mg/kg, ip) from saline. Data 
in represent the mean percent responding on the cocaine-appropriate lever (±SE) 
during the generalization sessions following administration of (±) 7-OH-DPAT (0–1 
mg/kg, ip) in rats pretreated with l-THP (1.875 or 3.75 mg/kg, ip) or vehicle (Veh). 
(±) 7-OH-DPAT dose-dependently substituted for cocaine. At the 0.3 mg/kg (±) 7-OH-
DPAT dose, substitution was significantly reduced compared to Veh pretreated rats by 
both l-THP doses (*P<0.05). 
4. Discussion 
Previously we and others reported that l-THP attenuated cocaine 
SA under FR (Mantsch et al., 2007; Xi et al., 2007) and PR (Xi et al., 
2007) schedules, cocaine-evoked reinstatement (Mantsch et al., 2007) 
and cocaine-induced reductions in ICSS thresholds (Xi et al., 2007), 
suggesting that l-THP may have potential as a pharmacotherapeutic 
agent for use in drug-dependent populations. The present study 
extends these findings to include attenuation of cocaine’s 
discriminative stimulus effects and further demonstrates that 
attenuation of cocaine’s reinforcing and subjective effects by l-THP can 
likely be accomplished at doses that do not produce marked motor 
impairment or anhedonic effects and may therefore be well tolerated. 
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The effects of l-THP on cocaine’s discriminative stimulus and 
reinforcing effects most likely stem from its actions at DA receptors 
(Jin, 1987). Roles for DA in cocaine’s discriminative stimulus (Callahan 
et al., 1997) and reinforcing (Anderson and Pierce, 2005) effects have 
been well established. Drugs that interfere with DA actions at D1 
(Kleven et al., 1988; Barrett and Appel, 1989; Kleven et al., 1990; 
Vanover et al., 1991; Witkin et al., 1991; Sinnott and Nader, 2001), 
D2 (Barrett and Appel, 1989; Kleven et al., 1990; Costanza et al., 
2001), or D3 (Beardsley et al., 2001; Martelle et al., 2007) DA 
receptors through antagonism or partial agonism have been reported 
to attenuate cocaine’s discriminative stimulus properties, while 
agonists at D1 (Callahan et al., 1991; Spealman et al., 1991; Witkin et 
al., 1991; Sinnott and Nader, 2001; Chausmer and Katz, 2002), D2 
(Callahan et al., 1991; Spealman et al., 1991; Witkin et al., 1991; 
Callahan and Cunningham, 1993; Katz and Witkin, 1992), or D3 (Acri 
et al., 1995; Lamas et al., 1996; Spealman, 1996; Sinnot et al., 1999) 
receptors have been reported to promote cocaine generalization in 
drug discrimination protocols. Likewise D1 (Hubner and Moreton, 
1991; Depoortere et al., 1993), D2 (Roberts et al., 1989; Hubner and 
Moreton, 1991) and D3 (Xi et al., 2005; 2006) DA receptor 
antagonists have been reported to reduce breaking points for cocaine 
SA under a PR schedule, while D1 (Rowlett et al., 2007), D2 (Rowlett 
et al., 2007), and D3 (Caine and Koob, 1995) receptor agonists have 
been reported to have the opposite effect. 
A large body of data suggests that l-THP binds to D1 and D2 DA 
receptors (Jin, 1987; Guo et al., 1997; Mantsch et al., 2007), likely 
functioning as an antagonist as measured using a number of indices 
(Jin et al., 1986; Xu et al., 1989; Wu et al., 1990; Zhu et al., 1991; 
Huang and Jin, 1992; Sun et al., 1992; Hu and Jin, 1999; Mantsch et 
al., 2007). We have also found that l-THP binds to the D3 receptor 
(Mantsch et al., 2007) at concentrations reached in the brain following 
systemic administration of doses comparable to those used in the 
present study (Hong et al., 2006), likely functioning as an antagonist. 
To examine the potential role of l-THP antagonism of D2 and D3 
receptors in its effects, we examined the ability of l-THP to block 
substitution of the D2/D3 agonist, (±) 7-OH-DPAT, for cocaine. As has 
been previously reported (Acri et al., 1995; Lamas et al., 1996; Baker 
et al., 1998; Sinnott et al., 1999; Caine et al., 2000; Ukai et al., 
2005), (±) 7-OH-DPAT dose-dependently substituted for cocaine. Like 
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cocaine, the dose-response curve for (±) 7-OH-DPAT substitution was 
shifted to the right by l-THP pretreatment. Although 7-OH-DPAT has 
approximately a 100-fold higher affinity for D3 receptors relative to D2 
receptors (Lévesque et al., 1992) it has been found that both D2 and 
D3 receptors contribute to its cocaine-like discriminative stimulus 
effects (Baker et al., 1998; Garner and Baker, 1999; Ukai et al., 
2005), suggesting a possible role for D2 and/or D3 antagonism in the 
effects of l-THP. Determination of the relative role of D2 vs. D3 
receptor antagonism, as well as the role of D1 receptor antagonism in 
the effects of l-THP on cocaine discrimination, will require further 
investigation. 
While we consider it likely that the effects of l-THP on cocaine 
discrimination and SA are attributable to DA receptor antagonism, it 
should be noted that l-THP does interact with a number of other 
receptors, including alpha-1 adrenergic receptors, at which it functions 
as an antagonist (Lu et al., 1996), and gamma-aminobutyric acid 
(GABA)A receptors, at which it facilitates GABA binding through 
positive allosteric effects (Halbsguth et al., 2003). The contribution of 
these mechanisms to the effects of l-THP will require further 
investigation. Despite its use as an analgesic agent, no interaction of l-
THP with opioid receptors has been documented, and its analgesic 
effects are naloxone-independent (Hu and Jin, 1999). 
Consistent with the findings of Xi et al (2007) l-THP dose-
dependently reduced cocaine SA under a PR schedule. The effects of l-
THP on PR cocaine SA appeared to represent a rightward shift in the 
dose-responses curve, consistent with a reduction in cocaine’s 
reinforcing effects and similar to the rightward shift in FR cocaine SA 
following l-THP administration observed by Xi et al. (2007). Effects on 
PR cocaine SA were observed at each l-THP dose tested, although 
significant effects of the 1.875 mg/kg dose of l-THP were only 
observed when examined as an overall effect across both cocaine 
doses. Notably, Xi et al. (2007) found effects on both PR and FR 
cocaine SA at l-THP doses as low as 1 mg/kg (ip). By contrast, effects 
on both response rate and breaking points for food SA under an 
identical PR schedule were only observed at the highest l-THP dose 
tested (i.e., 7.5 mg/kg). Importantly, the reinforcing efficacies of 
cocaine and food were matched in this study such that breaking points 
were equivalent in the absence of l-THP treatment. These findings 
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support our previous findings that l-THP attenuated cocaine SA under 
a FR schedule and cocaine-induced reinstatement at doses that failed 
to alter concurrently measured food- or sucrose-reinforced lever 
pressing under FR schedules (Mantsch et al., 2007; Xi et al., 2007). 
Likewise, in our drug discrimination experiment, l-THP failed to alter 
response rate during generalization testing at a doses (i.e., 1.875 and 
3.75 mg/kg) that significantly attenuated cocaine generalization. 
Although we have previously found that the 3.75 mg/kg dose of l-THP 
reduces locomotor activity (Mantsch et al., 2007), Xi et al. (2007) 
reported that a comparable dose of l-THP (i.e., 3 mg/kg, ip) has no 
effect. 
The viability of DA antagonist drugs as medications for cocaine 
addiction has been greatly limited by a range of side effects, including 
sedation and anhedonia. Further, l-THP-containing preparations have 
been used for their sedative properties and the primary clinical feature 
of overdose intoxication with such preparations is central nervous 
system depression (Horowitz et al., 1996). The observed dose 
separation between the effects of l-THP on drug seeking and motoric 
effects as measured by lever pressing for a non-drug reinforcer or 
locomotor activity and potential anhedonic effects as measured by 
sucrose-sweetened pellet PR SA breaking points and ICSS thresholds 
(Xi et al., 2007) suggests that l-THP may have more desirable safety 
profile when compared to other DA antagonist drugs. Although the 
efficacy and safety of l-THP in human cocaine-dependent populations 
has not been reported, the potential utility of l-THP for the treatment 
of addiction is supported by the findings of a recent preliminary clinical 
trial suggesting that l-THP may reduce drug craving and relapse in 
recovering heroin addicts (Yang et al., 2008). Clinical testing of l-THP 
effectiveness in the US awaits further examination of its safety for use 
in human populations. 
5.1. Conclusions 
To summarize, the present findings extend previous preclinical 
findings (Mantsch et al., 2007; Xi et al., 2007) and support the recent 
clinical report (Yang et al., 2008) suggesting that l-THP has 
therapeutic utility for the treatment of addiction. Although sedative 
properties of l-THP may limit its use, we were able to attenuate 
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cocaine’s discriminative stimulus and reinforcing effects at l-THP doses 
that had little or no effects on food-reinforced responding during the 
same session, in the case of the drug discrimination experiment, or in 
separate rats self-administering food pellets under an identical PR 
schedule. Characterization of the unique pharmacological effects of l-
THP and other similar compounds, in particular their actions at DA 
receptors, may provide insight into drug profiles and/or combinations 
that may be effective for managing cocaine addiction. 
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